Seeking Alpha
29 Sept 2026, 00:43 UTC · 1h ago
Quince Therapeutics, Inc. (QNCX) Discusses LAM-001 Clinical Progress in Pulmonary Hypertension and Bronchiolitis Obliterans Syndrome Transcript
Verdict
Headline takes no side. We score QNCX +0.50 — strongly bullish.
- Expected · QNCX
+0.50strongly bullish
−1 bearish0bullish +1More positive than 71% of ticker scores this week





